Premium Information is available for this item - Upgrade for $1 a day
1680-01-485-9443
Indicator Panel
1680014859443 014859443 KD84101-003
A panel designed for indicating purposes only. It does not distribute power nor control the equipment with which it is used. See also PANEL, POWER DISTRIBUTION; SWITCHBOARD, POWER and INDICATOR ASSEMBLY. View more Indicator Panel
![]()
January 2023
3

Marketplace 1680-01-485-9443
Request a Quotation from participating marketplace vendors
Related Documents 1680-01-485-9443 1+ Documents (More...)
United States (US) 4. 1680-01-485-9443 Marketplace Restrictions Approved Sources Datasheet Management
RQST NE Updated Every Day 1680-01-485-9443 RQST Updated Every Day 1680-01-485-9443 RQST NE Restrictions
Restrictions 1680-01-485-9443
1680-01-485-9443 is a Indicator Panel that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. This item has been confirmed as a Critical Munitions List Item or a Sensitive Commerce Control List Item and cannot be in the possession of any party anywhere in the World who is not an authorized NATO Government. Any other possessor of this item should mutilate it now as possession violates international and local laws. This item is a US Munitions List Item and must be mutilated to scrap. This item is not suspected to be hazardous. This item does not contain a precious metal.
Import and Export 1680-01-485-9443
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 1680-01-485-9443
- New Zealand (ZE01)
- Effective Date:
- 1 Jun 2001
Approved Sources 1680-01-485-9443
- Part Number
- Manufacturer
- Status
- KD84101-003
- Manufacturer
- 84955 - Kaman Aerospace Corporation (Active)
- Primary Buy
- Primary Buy
Similar Supply Items to 1680-01-485-9443


















Freight Information 1680-01-485-9443
1680-01-485-9443 has freight characteristics managed by New Zealand.. 1680-01-485-9443 has a variance between NMFC and UFC when transported by rail and the description should be consulted.